This content is machine translated Tetanus toxin The first active ingredient against muscle loss Stroke, multiple sclerosis or spinal cord injuries are among the most common neurological diseases in which permanent paralysis and muscle atrophy can result from a disorder in the central nervous…
View Post 5 min This content is machine translated Keloid treatment Avoid unsightly traces Scars are the permanent remaining sign of deeper injuries of the skin and are formed in the course of physiological wound healing. While people generally come to terms with physiological…
View Post 5 min This content is machine translated Venous thromboembolism Clinical assessment and anticoagulant therapy – an update. If thromboembolism is not detected and treated in time, life-threatening consequences may result. Validated tests, such as the Wells score and the D-dimer test, can be used to assess the…
View Post 1 min This content is machine translated Data put in perspective Five years of ustekinumab in Crohn’s disease Long-term data confirm safety and efficacy of ustekinumab: The UNITI study evaluated the efficacy and safety of intravenous induction therapy with ustekinumab followed by subcutaneous maintenance therapy and an extension phase…
View Post 4 min This content is machine translated Heart Health Focus on prevention, diagnosis and management of cardiovascular diseases Exciting questions and current research findings related to heart health were discussed at this year’s ESC. The main focus was on prevention strategies, diagnostics and the management of cardiovascular diseases.…
View Post 4 min This content is machine translated SUSTAIN-10: Post-hoc analysis Semaglutide and liraglutide in type 2 diabetes: effective and safe with and without SGLT-2-i Based on empirical evidence, professional societies recommend early combination of metformin with an SGLT-2 inhibitor or a GLP-1 receptor agonist in type 2 diabetics. Increasingly, a combined application of the…
View Post 6 min This content is machine translated Practice Changing The most important studies at a glance As usual, at this year’s Congress of the European Society for Medical Oncology (ESMO), those studies with the greatest impact on daily practice were presented in three so-called Presidential Symposia. We…
View Post 3 min This content is machine translated Biomarker-based stratification Prediction of the therapy response of atopic patients In the context of new targeted therapies and the goal of precision medicine, stratification of patients based on their endotype is becoming increasingly important. Using the method of “deep phenotyping,”…
View Post 5 min This content is machine translated Chronic pruritus Management of intractable pruritus – new therapeutic options available soon? Persistent itching is very stressful for those affected and can lead to enormous suffering. A careful diagnostic clarification of chronic pruritus is the basis for a goal-oriented treatment. It remains…
View Post 14 min This content is machine translated Gastrointestinal carcinomas New therapy options in 2021 Malignant tumors of the gastrointestinal tract are common, and the need for additional therapeutic options is high. At this year’s ASCO Annual Meeting, exciting new study results were presented for… CME-Test
View Post 8 min This content is machine translated Advanced breast carcinoma What’s new? With antibody-drug conjugates, checkpoint and CDK4/6 inhibitors, three drug classes were in the spotlight at this year’s European Society for Medical Oncology (ESMO) congress in advanced breast cancer. This is…
